Graham Pawelec received an MA in Natural Sciences and a PhD in Transplantation Immunology from the University of Cambridge, UK. He is currently Professor of Experimental Immunology at the Center for Medical Research, Second Department of Internal Medicine, University of Tübingen Medical School, Tübingen, Germany. He is a Visiting Professor, Nottingham Trent University, UK and at King´s College London, holds an Honorary Chair at Manchester University, UK and acts as a “Cancer Solutions Consultant” at the Health Sciences North Research Insitute of Canada, Sudbury, ON. He is Co-Editor-in-Chief of “Cancer Immunology Immunotherapy” and Deputy Editor of the “Journal of Translational Medicine” and “Immunity and Aging”.

Research interests are currently centered on alterations to immunity, especially T cell-mediated immunity, in ageing and cancer in man, and the influence these have on the outcome of vaccination and immunomodulatory antibody therapies. The impact of polypathogenicity (including multiple infections, cancer, Alzheimer´s, diabetes, autoimmunity) as well as stress (psychological, nutritional) on immune signatures reflecting individual immune status is of particular interest in the clinical context.